DISEASE INDICATIONS: Asthma MANUFACTURER: Amgen / AstraZeneca AB USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Tezspire (tezepelumab-ekko) is a medication prescribed as an add-on maintenance treatment for individuals aged 12 years and older, both adult and pediatric, with severe asthma.